For example, three other drugs, irbesartan, pseudoephedrine and vinblastine, can target JUN (Figure 6), indicating that the three drugs may affect the pan-cancer FFL JUN_hsa-miR-21-5p_MSH2 through mediating their drug target JUN as the mechanism of ATO. This evidence concerns the gene JUN and cancer.